BIT 0.00% 3.3¢ biotron limited

calm before the storm?, page-17

  1. 2,304 Posts.
    lightbulb Created with Sketch. 328
    Hi n_terra,

    BIT has referred (twice) to results from the second stage of the PhII HCV trails being released mid 2011. I expect this means June or July.

    from 31 March 2011 presentation to investors-
    "Status - trial commenced Sept 2010 and due to complete 2Q 2011 12/24 patients completed to date"

    from 10 March 2011 announcement-
    "Twelve patients have been dosed in the first half of the trial being undertaken by ACLIRES, an international contract research organisation (CRO) that specialises in running antiviral drug clinical trials. All are infected with the most common strain of the Hepatitis C virus, genotype 1. The second half of the trial - which also involves 12 patients - is now underway and expected to be
    completed in May, with results anticipated to be analysed and released in June. The trial is blinded, so no results are available until samples are analysed at the conclusion of the trial and the data is unblinded."

    bluebush
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.